These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2503991)

  • 41. [Construction of recombinant BCG bearing Schistosoma japonicum 26Ku antigen gene and study on its immunogenicity on mice].
    Dai W; Huangfu Y; Zheng B
    Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):407-10. PubMed ID: 11798793
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transformation of Mycobacterium smegmatis with Escherichia coli plasmids carrying a selectable resistance marker.
    Zainuddin ZF; Kunze ZM; Dale JW
    Mol Microbiol; 1989 Jan; 3(1):29-34. PubMed ID: 2654539
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Site-specific integration of the Streptomyces plasmid pSAM2 in Mycobacterium smegmatis.
    Martín C; Mazodier P; Mediola MV; Gicquel B; Smokvina T; Thompson CJ; Davies J
    Mol Microbiol; 1991 Oct; 5(10):2499-502. PubMed ID: 1665195
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Construction of a pair of practical Nocardia-Escherichia coli shuttle vectors.
    Chiba K; Hoshino Y; Ishino K; Kogure T; Mikami Y; Uehara Y; Ishikawa J
    Jpn J Infect Dis; 2007 Feb; 60(1):45-7. PubMed ID: 17314425
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Shuttle vectors developed from Streptococcus thermophilus native plasmid.
    Solaiman DK; Somkuti GA
    Plasmid; 1993 Jul; 30(1):67-78. PubMed ID: 8378446
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Electroporation of mycobacteria.
    Goude R; Parish T
    Methods Mol Biol; 2009; 465():203-15. PubMed ID: 20560076
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Site-specific integration of mycobacteriophage L5: integration-proficient vectors for Mycobacterium smegmatis, Mycobacterium tuberculosis, and bacille Calmette-Guérin.
    Lee MH; Pascopella L; Jacobs WR; Hatfull GF
    Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3111-5. PubMed ID: 1901654
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A stable Escherichia coli-mycobacteria shuttle vector 'pSO246' in Mycobacterium bovis BCG.
    Matsumoto S; Tamaki M; Yukitake H; Matsuo T; Naito M; Teraoka H; Yamada T
    FEMS Microbiol Lett; 1996 Jan; 135(2-3):237-43. PubMed ID: 8595863
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gene replacement and expression of foreign DNA in mycobacteria.
    Husson RN; James BE; Young RA
    J Bacteriol; 1990 Feb; 172(2):519-24. PubMed ID: 2153655
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heterologous expression of genes in mycobacteria.
    Triccas JA; Ryan AA
    Methods Mol Biol; 2009; 465():243-53. PubMed ID: 20560073
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The development of a novel Mycobacterium-Escherichia coli shuttle vector system using pMyong2, a linear plasmid from Mycobacterium yongonense DSM 45126T.
    Lee H; Kim BJ; Kim BR; Kook YH; Kim BJ
    PLoS One; 2015; 10(3):e0122897. PubMed ID: 25822634
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of a new host vector system in mycobacteria.
    Goto Y; Taniguchi H; Udou T; Mizuguchi Y; Tokunaga T
    FEMS Microbiol Lett; 1991 Oct; 67(3):277-82. PubMed ID: 1769534
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors affecting transformation efficiency of BCG with a Mycobacterium-Escherichia coli shuttle vector pYUB18 by electroporation.
    Cho SN; Hwang JH; Park S; Chong Y; Kim SK; Song CY; Kim JD
    Yonsei Med J; 1998 Apr; 39(2):141-7. PubMed ID: 9587254
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Construction of shuttle vectors for genetic manipulation and molecular analysis of mycobacteria.
    Jain S; Kaushal D; DasGupta SK; Tyagi AK
    Gene; 1997 Apr; 190(1):37-44. PubMed ID: 9185847
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Progress on development of the live BCG recombinant vaccine vehicle for combined vaccine delivery.
    Hanson MS; Lapcevich CV; Haun SL
    Ann N Y Acad Sci; 1995 May; 754():214-21. PubMed ID: 7625654
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Instability and site-specific excision of integration-proficient mycobacteriophage L5 plasmids: development of stably maintained integrative vectors.
    Springer B; Sander P; Sedlacek L; Ellrott K; Böttger EC
    Int J Med Microbiol; 2001 Mar; 290(8):669-75. PubMed ID: 11310445
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insertional mutagenesis and illegitimate recombination in mycobacteria.
    Kalpana GV; Bloom BR; Jacobs WR
    Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5433-7. PubMed ID: 2052623
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cloning and assessment of mycobacterial promoters by using a plasmid shuttle vector.
    Das Gupta SK; Bashyam MD; Tyagi AK
    J Bacteriol; 1993 Aug; 175(16):5186-92. PubMed ID: 8349558
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Apramycin resistance as a selective marker for gene transfer in mycobacteria.
    Paget E; Davies J
    J Bacteriol; 1996 Nov; 178(21):6357-60. PubMed ID: 8892841
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Construction and use of integrative vectors to express foreign genes in mycobacteria.
    Dellagostin OA; Wall S; Norman E; O'Shaughnessy T; Dale JW; McFadden J
    Mol Microbiol; 1993 Dec; 10(5):983-93. PubMed ID: 7934874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.